These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 38007933)
1. Tweak/Fn14 system is involved in rhabdomyolysis-induced acute kidney injury. Guerrero-Hue M; Vallejo-Mudarra M; García-Caballero C; Córdoba-David GM; Palomino-Antolín A; Herencia C; Vendrell-Casana B; Rubio-Navarro A; Egido J; Blanco-Colio LM; Moreno JA Biomed Pharmacother; 2023 Dec; 169():115925. PubMed ID: 38007933 [TBL] [Abstract][Full Text] [Related]
2. Out of the TWEAKlight: Elucidating the Role of Fn14 and TWEAK in Acute Kidney Injury. Sanz AB; Ruiz-Andres O; Sanchez-Niño MD; Ruiz-Ortega M; Ramos AM; Ortiz A Semin Nephrol; 2016 May; 36(3):189-98. PubMed ID: 27339384 [TBL] [Abstract][Full Text] [Related]
4. TWEAK and RIPK1 mediate a second wave of cell death during AKI. Martin-Sanchez D; Fontecha-Barriuso M; Carrasco S; Sanchez-Niño MD; Mässenhausen AV; Linkermann A; Cannata-Ortiz P; Ruiz-Ortega M; Egido J; Ortiz A; Sanz AB Proc Natl Acad Sci U S A; 2018 Apr; 115(16):4182-4187. PubMed ID: 29588419 [TBL] [Abstract][Full Text] [Related]
5. A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis. Méndez-Barbero N; Gutierrez-Muñoz C; Madrigal-Matute J; Mínguez P; Egido J; Michel JB; Martín-Ventura JL; Esteban V; Blanco-Colio LM EBioMedicine; 2019 Aug; 46():274-289. PubMed ID: 31395500 [TBL] [Abstract][Full Text] [Related]
6. Interruption of neutrophil extracellular traps formation dictates host defense and tubular HOXA5 stability to augment efficacy of anti-Fn14 therapy against septic AKI. Ni Y; Hu BC; Wu GH; Shao ZQ; Zheng Y; Zhang R; Jin J; Hong J; Yang XH; Sun RH; Liu JQ; Mo SJ Theranostics; 2021; 11(19):9431-9451. PubMed ID: 34646379 [TBL] [Abstract][Full Text] [Related]
7. TWEAK-Fn14 as a common pathway in the heart and the kidneys in cardiorenal syndrome. Poveda J; Vázquez-Sánchez S; Sanz AB; Ortiz A; Ruilope LM; Ruiz-Hurtado G J Pathol; 2021 May; 254(1):5-19. PubMed ID: 33512736 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis. Xia Y; Campbell SR; Broder A; Herlitz L; Abadi M; Wu P; Michaelson JS; Burkly LC; Putterman C Clin Immunol; 2012 Nov; 145(2):108-21. PubMed ID: 22982296 [TBL] [Abstract][Full Text] [Related]
9. Cytokine cooperation in renal tubular cell injury: the role of TWEAK. Justo P; Sanz AB; Sanchez-Niño MD; Winkles JA; Lorz C; Egido J; Ortiz A Kidney Int; 2006 Nov; 70(10):1750-8. PubMed ID: 17003819 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of suppressor of cytokine signaling 1 mediates the profibrotic effect of TWEAK/Fn14 signaling on kidney cells. Chen J; Jia F; Ren K; Luo M; Min X; Wang P; Xiao S; Xia Y Cell Signal; 2020 Jul; 71():109615. PubMed ID: 32217132 [TBL] [Abstract][Full Text] [Related]
11. The TNF-like weak inducer of the apoptosis/fibroblast growth factor-inducible molecule 14 axis mediates histamine and platelet-activating factor-induced subcutaneous vascular leakage and anaphylactic shock. Mendez-Barbero N; Yuste-Montalvo A; Nuñez-Borque E; Jensen BM; Gutiérrez-Muñoz C; Tome-Amat J; Garrido-Arandia M; Díaz-Perales A; Ballesteros-Martinez C; Laguna JJ; Beitia JM; Poulsen LK; Cuesta-Herranz J; Blanco-Colio LM; Esteban V J Allergy Clin Immunol; 2020 Feb; 145(2):583-596.e6. PubMed ID: 31679818 [TBL] [Abstract][Full Text] [Related]
12. Interaction of TWEAK with Fn14 leads to the progression of fibrotic liver disease by directly modulating hepatic stellate cell proliferation. Wilhelm A; Shepherd EL; Amatucci A; Munir M; Reynolds G; Humphreys E; Resheq Y; Adams DH; Hübscher S; Burkly LC; Weston CJ; Afford SC J Pathol; 2016 May; 239(1):109-21. PubMed ID: 26924336 [TBL] [Abstract][Full Text] [Related]
13. TWEAK/Fn14 Activation Participates in Skin Inflammation. Liu Q; Xiao S; Xia Y Mediators Inflamm; 2017; 2017():6746870. PubMed ID: 29038621 [TBL] [Abstract][Full Text] [Related]
16. Emerging role of TWEAK-Fn14 axis in lupus, a disease related to autoimmunity and fibrosis. Xu Y; Wei HT; Jing HY; Tan XY; Zhou XT; Ma YR Int J Rheum Dis; 2022 Jan; 25(1):21-26. PubMed ID: 34716660 [TBL] [Abstract][Full Text] [Related]
17. TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus. Zhao Z; Burkly LC; Campbell S; Schwartz N; Molano A; Choudhury A; Eisenberg RA; Michaelson JS; Putterman C J Immunol; 2007 Dec; 179(11):7949-58. PubMed ID: 18025243 [TBL] [Abstract][Full Text] [Related]
18. Tweak induces proliferation in renal tubular epithelium: a role in uninephrectomy induced renal hyperplasia. Sanz AB; Sanchez-Niño MD; Izquierdo MC; Jakubowski A; Justo P; Blanco-Colio LM; Ruiz-Ortega M; Egido J; Ortiz A J Cell Mol Med; 2009 Sep; 13(9B):3329-42. PubMed ID: 19426154 [TBL] [Abstract][Full Text] [Related]
19. TWEAK-Fn14 Signaling Activates Myofibroblasts to Drive Progression of Fibrotic Kidney Disease. Gomez IG; Roach AM; Nakagawa N; Amatucci A; Johnson BG; Dunn K; Kelly MC; Karaca G; Zheng TS; Szak S; Peppiatt-Wildman CM; Burkly LC; Duffield JS J Am Soc Nephrol; 2016 Dec; 27(12):3639-3652. PubMed ID: 27026366 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of fibroblast growth factor-inducible 14 attenuates experimental tubulointerstitial fibrosis and profibrotic factor expression of proximal tubular epithelial cells. Luo M; Liu M; Liu W; Cui X; Zhai S; Gu H; Wang H; Wu K; Zhang W; Li K; Xia Y Inflamm Res; 2021 May; 70(5):553-568. PubMed ID: 33755760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]